Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular Carcinoma
Monika Vyas, Xuchen Zhang
Clinics in Liver Disease (2020) Vol. 24, Iss. 4, pp. 591-610
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

The Role of TGF-β/SMAD Signaling in Hepatocellular Carcinoma: from Mechanism to Therapy and Prognosis
Xin Xin, Xiyu Cheng, Fanxin Zeng, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1436-1451
Open Access | Times Cited: 28
Treatment of hepatocellular carcinoma
Alejandro Forner, Amelia J. Hessheimer, María Isabel Real, et al.
Critical Reviews in Oncology/Hematology (2006) Vol. 60, Iss. 2, pp. 89-98
Closed Access | Times Cited: 164
Interleukin 22 in Liver Injury, Inflammation and Cancer
Ye Wu, Jie Min, Chang Ge, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 13, pp. 2405-2413
Open Access | Times Cited: 68
Generation and analysis of 3D cell culture models for drug discovery
Lisa Belfiore, Behnaz Aghaei‐Ghareh‐Bolagh, Andrew M. K. Law, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 163, pp. 105876-105876
Closed Access | Times Cited: 51
RETRACTED ARTICLE: Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis
Linpei Wang, Jing Lin, Xiaoqiu Ma, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 47
RNA m6A methylation regulators in liver cancer
Qiaoping Xu, Ning Ren, Lanqi Ren, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Pathologic and molecular features of hepatocellular carcinoma: An update
Mukul Vij, Julien Caldéraro
World Journal of Hepatology (2021) Vol. 13, Iss. 4, pp. 393-410
Open Access | Times Cited: 37
Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis
Huannan Meng, Mengqin Shen, Jiajin Li, et al.
European Journal of Pharmacology (2021) Vol. 906, pp. 174280-174280
Open Access | Times Cited: 37
A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma
Chang Liu, Zhen Wu, Liping Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12123-12123
Open Access | Times Cited: 18
Gadoxetic Acid–enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular Carcinoma
Kun Zhang, Kan He, Lei Zhang, et al.
Radiology (2025) Vol. 314, Iss. 2
Closed Access
Hepatocellular Carcinoma: A Comprehensive Review of Pathophysiology, Risk Factors, Diagnosis and Treatment Strategies
Vedika N. Dafe, Pooja R. Hatwar, Ravindra L. Bakal, et al.
Journal of Drug Delivery and Therapeutics (2025) Vol. 15, Iss. 5, pp. 159-165
Open Access
Cytoskeletal dynamics regulates stromal invasion behavior of distinct liver cancer subtypes
Ryan Nguyen, Hugh Xiao, Xiangyu Gong, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 14
Preliminary Study on Pharmacokinetics and Antitumor Pharmacodynamics of Folic Acid Modified Crebanine Polyethyleneglycol-Polylactic Acid Hydroxyacetic Acid Copolymer Nanoparticles
Xin Cheng, Rui Pan, Jiajing Tang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10513-10536
Open Access | Times Cited: 2
Role of TOP2A and CDC6 in liver cancer
Jia Wang, Xiang Liu, Zhilei Zhang
Medicine (2023) Vol. 102, Iss. 42, pp. e35604-e35604
Open Access | Times Cited: 6
Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism
Erlei Zhang, Zun-Yi Zhang, Zhiyong Huang
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 1, pp. 137-139
Open Access | Times Cited: 4
Frequent expression of PD-L1 in lymphocyte-rich hepatocellular carcinoma: A report of 4 cases
Mukul Vij, Fadl H. Veerankutty, Lexmi Priya Raju, et al.
Annals of Diagnostic Pathology (2023) Vol. 66, pp. 152172-152172
Closed Access | Times Cited: 4
E2F1-mediated GINS2 transcriptional activation promotes tumor progression through PI3K/AKT/mTOR pathway in hepatocellular carcinoma.
Yao Zhang, Xiaopei Hao, Guoyong Han, et al.
PubMed (2022) Vol. 12, Iss. 4, pp. 1707-1726
Closed Access | Times Cited: 7
Identification of key molecules in the formation of portal vein tumor thrombus in hepatocellular carcinoma based on single cell transcriptomics and in vitro experiments
Man Zhang, Chenglei Su, Xiaoyu Liu, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 4, pp. 1737-1761
Open Access | Times Cited: 1
Structure of POU2AF1 recombinant protein and it affects the progression and treatment of liver cancer based on WGCNA and molecular docking analysis
Xin Li, Hongxu Zhou, Ruiyang Ma, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134629-134629
Closed Access | Times Cited: 1
Lipidomic study and diagnosis of hepatocellular carcinoma tumor with rapid evaporative ionization mass spectrometry
Haixing Wang, Ting Li, Qing Shen, et al.
Electrophoresis (2023) Vol. 44, Iss. 13-14, pp. 1057-1067
Closed Access | Times Cited: 3
Hepatocellular carcinoma: Preclinical and clinical applications of nanotechnology with the potential role of carbohydrate receptors
Sanya Batheja, Rakesh Kumar Sahoo, Sofiya Tarannum, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 10, pp. 130443-130443
Closed Access | Times Cited: 3
Precise localization of microvascular invasion in hepatocellular carcinoma based on three-dimensional histology-MR image fusion: an ex vivo experimental study
Liujun Li, Jiaxin Chen, Yongquan Huang, et al.
Quantitative Imaging in Medicine and Surgery (2023) Vol. 13, Iss. 9, pp. 5887-5901
Open Access | Times Cited: 3
TATI modality: A new perspective on the treatment of advanced hepatocellular carcinoma
Ping Liang, Xin Ye, Xin Li
Journal of Cancer Research and Therapeutics (2020) Vol. 16, Iss. 5, pp. 957-957
Open Access | Times Cited: 7
E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma
Zhibo Tan, Min Chen, Feng Peng, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 8, pp. 2713-2732
Open Access | Times Cited: 4
Drug-eluting bead transarterial chemoembolization could improve the hepatic hemodynamics of patients with unresectable hepatocellular carcinoma: a retrospective cohort study
Tao Wang, Yanan Du, Jiewei Sun, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 1, pp. 302-311
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top